The outlook of companies tied to flagship drugs like Viagra presents a challenging investment picture. While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the patent expiration in key markets has introduced considerable uncertainty . Investors are now assessing the effect of generic competit